SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-078600
Filing Date
2024-07-09
Accepted
2024-07-09 17:18:46
Documents
14
Period of Report
2024-07-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2419145d1_8k.htm   iXBRL 8-K 28374
2 EXHIBIT 99.1 tm2419145d1_ex99-1.htm EX-99.1 13054
  Complete submission text file 0001104659-24-078600.txt   223089

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ganx-20240709.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20240709_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20240709_pre.xml EX-101.PRE 22375
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2419145d1_8k_htm.xml XML 3794
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 241108135
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)